$0.30
0.00% yesterday
Nasdaq, Jun 26, 07:29 pm CET
ISIN
US43358Y1038
Symbol
HSTO
Sector
Industry

Histogen Inc Share price

$0.30
+0.13 76.47% 1M
-0.02 5.96% 6M
-0.01 2.50% YTD
-0.42 58.36% 1Y
-22.30 98.67% 3Y
-56.30 99.47% 5Y
-1,603.70 99.98% 10Y
Nasdaq, Closing price Wed, Jun 26 2024
ISIN
US43358Y1038
Symbol
HSTO
Sector
Industry

Key figures

Market capitalization $1.28m
Enterprise Value $-4.62m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.46
EV/Sales (TTM) EV/Sales -231.00
P/S ratio (TTM) P/S ratio 64.00
P/B ratio (TTM) P/B ratio 0.24
Sales growth (TTM) Sales growth -99.50%
Turnover (TTM) Turnover $20.00k
EBIT (operating result TTM) EBIT $-12.08m
Free cash flow (TTM) Free cash flow $-10.08m
Cash position $4.87m
EPS (TTM) EPS $-2.90
Short interest 1.62%
Show more

Is Histogen Inc a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,947 shares worldwide.

Histogen Inc Share analysis

Unlock scores for free

Analyst opinions

1 Analyst has issued a forecast Histogen Inc:

1x Buy
100%

Analyst opinions

1 Analyst has issued a forecast Histogen Inc:

Buy
100%

Financial data from Histogen Inc

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Sep '23
+/-
%
0.02 0.02
99% 99%
100%
- Direct costs 0.18 0.18
157% 157%
900%
-0.16 -0.16
104% 104%
-800%
- Selling and administrative expenses 8.47 8.47
6% 6%
42,350%
- Research and development costs 3.28 3.28
41% 41%
16,400%
-12 -12
-
-59,550%
- Depreciation and amortization 0.18 0.18
-
900%
EBIT (operating result) EBIT -12 -12
12% 12%
-60,420%
Net profit -12 -12
15% 15%
-61,900%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Histogen Inc share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Histogen Inc Share News

Neutral
GlobeNewsWire
2 months ago
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO, the “Company” or “Histogen”), a drug development company for treatment of bacterial skin infections, today announced that it has filed voluntary petitions for relief under subchapter V of Chapter 11 of the U.S. Bankruptcy Code (“Chapter 11”) in the United States Bankruptcy Court for the Southern District of California to confirm...
Neutral
GlobeNewsWire
7 months ago
Meeting Adjourned for a Final Time to January 4, 2024 at 8:00 a.m. PT Potential Estimated Cash Distribution to Shareholders of $0.30 to $0.41 if Dissolution Proposal Approved
Neutral
GlobeNewsWire
7 months ago
SAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (OTC: HSTO) today announced that its special meeting of stockholders (the “Special Meeting”) has been adjourned to Thursday, December 14, 2023 at 8:00 a.m. Pacific Time with respect to both proposals described in its definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 18, 2023 (the “P...
More Histogen Inc News

Company profile

Histogen, Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. The company engages in research, development, and manufacturing of products derived from its technology. It offers an insoluble human extracellular matrix (hECM); and a soluble complex of proteins. The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. It has joint venture with PUR Biologics, Adaptive Biologix, and Histogen Aesthetics to develop additional products. Histogen, Inc. was founded in 2007 and is based in San Diego, California.

Head office United States
CEO Susan Knudson
Employees 7
Founded 2005
Website www.histogen.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now